Gulcelik Mehmet A, Dinc Soykan, Bir Ferda, Elitok Orhan, Alagol Haluk, Oz Murat
Department of General Surgery, Ankara Oncology Training and Research Hospital, Demetevler, Ankara.
Can J Surg. 2005 Jun;48(3):213-8.
Several systemic factors, including jaundice, long-term corticosteroid therapy, diabetes and malnutrition, increase the risk of anastomotic dehiscence. The local application of molgramostim (recombinant human granulocyte-macrophage colony stimulating factor) has been reported to improve impaired dermal wound healing. Since jaundice, one of the systemic risk factors for anastomotic dehiscence, causes significant impairment of anastomotic healing, we hypothesized that locally injected molgramostim could improve the healing of bowel anastomoses in bile-duct-ligated rats used as an experimental model for jaundice.
Eighty-six Sprague-Dawley rats were randomized into 4 groups of 20-22 animals each as follows: group 1--colonic anastomosis only; group 2--laparotomy followed 7 days later by colonic anastomosis; group 3--common-bile-duct ligation (CBDL) followed 7 days later by colonic anastomosis (control group); group 4--CBDL followed by colonic anastomosis with locally applied molgramostim. Laparotomy was performed under anesthesia in group 2 rats. In groups 3 and 4, laparotomy was followed by ligation and dissection of the common bile duct. After 7 days, colonic anastomosis was performed; in group 4 rats, molgramostim (50 microg) was injected into the perianastomotic area. On postoperative day 3, rats were killed, and the bursting pressures and hydroxyproline levels measured. Two rats from each group were selected for histopathological examination.
The mean bursting pressure in group 4 was significantly higher than that in group 3 (37.8 v. 30.5 mm Hg [p < 0.01]). The mean hydroxyproline level in group 3 was significantly lower than that of the other groups (2.7 v. 3.1-3.5 mg/g tissue [p < 0.01]). On histopathological examination, specimens from group 4 rats showed an increased mononuclear cell population and a smaller gap on the anastomotic line than those from group 3.
The local injection of molgramostim improves healing of the impaired wound in rats subjected to CBDL.
包括黄疸、长期使用皮质类固醇治疗、糖尿病和营养不良在内的多种全身因素会增加吻合口裂开的风险。据报道,局部应用莫拉司亭(重组人粒细胞巨噬细胞集落刺激因子)可改善受损的皮肤伤口愈合。由于黄疸是吻合口裂开的全身危险因素之一,会导致吻合口愈合严重受损,我们推测局部注射莫拉司亭可改善胆管结扎大鼠肠吻合口的愈合,胆管结扎大鼠用作黄疸的实验模型。
86只Sprague-Dawley大鼠随机分为4组,每组20 - 22只动物,分组如下:第1组——仅行结肠吻合术;第2组——剖腹术后7天行结肠吻合术;第3组——胆总管结扎(CBDL)术后7天行结肠吻合术(对照组);第4组——CBDL术后行结肠吻合术并局部应用莫拉司亭。第2组大鼠在麻醉下进行剖腹术。在第3组和第4组中,剖腹术后进行胆总管结扎和解剖。7天后,进行结肠吻合术;在第4组大鼠中,将莫拉司亭(50微克)注入吻合口周围区域。术后第3天,处死大鼠,测量破裂压力和羟脯氨酸水平。每组选取2只大鼠进行组织病理学检查。
第4组的平均破裂压力显著高于第3组(37.8对30.5毫米汞柱[p < 0.01])。第3组的平均羟脯氨酸水平显著低于其他组(2.7对3.1 - 3.5毫克/克组织[p < 0.01])。组织病理学检查显示,第4组大鼠的标本与第3组相比,单核细胞数量增加,吻合线上的间隙更小。
局部注射莫拉司亭可改善胆管结扎大鼠受损伤口的愈合。